Academic Articles

Selected Highlights



Emerging Ethical Issues Raised by Highly Portable MRI Research in Remote and Resource-Limited International Settings NeuroImage (in press)


MacDuffie KE, Grubbs L, Best T, LaRoche S, Mildon B, Myers L, Stafford E, Rommelfanger KS*. Stigma and functional neurological disorder: a research agenda targeting the clinical encounter. CNS Spectr. Dec 3:1-6 (2020).

Rommelfanger KS*, Rapaport MH. Setting a Research Agenda for FND. CNS Spectr. Oct 7:1-3 (2020).

Rommelfanger KS*. AJOB Neuroscience Reflecting on a Neuroethics Roadmap in a Global Crisis 11(3):131-134 (2020).

International Brain Initiative (Bjaalie, J, Rommelfanger, KS as co-author with group) International Brain Initiative and Innovative Framework for Coordinated Global Brain Research Efforts Neuron 105 (2) 212-216 (2020).

Pick S et al….Rommelfanger KS et al. Outcome measurement in functional neurological disorder: a systematic review and recommendations. J Neurol Neurosurg Psychiatry 91(6):638-649 (2020).

Nicholson TR et al,…Rommelfanger, KS et al. Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities J Neuropsychiatry Clin Neurosci 32(1): 33-42 (2020).


Rommelfanger KS*, Jeong S-J, Montojo C, Zirlinger, M. Neuroethics: Think Global. Neuron 101: 363-364 (2019).

Doraiswamy PM et al,…Rommelfanger KS et al. Empowering 8 Billion Minds: Enabling Better Mental Health for All via Enabling the Ethical Adoption of Technologies National Academy of Medicine Discussion Paper, National Academy of Medicine, Washington, DC 1-23 (2019)

Hendriks S, Grady C, Ramos KM, et al, Rommelfanger K, et al. Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review.  JAMA Neurol. 76(12): 1506-1514 (2019).

Ahlgrim N, Garza K, Hoffman C, and Rommelfanger KS*. Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health eNeuro 6(4) (2019).

Ramos KM, et al…Rommelfanger KS et al. The NIH BRAIN Initiative: Integrating Neuroethics and Neuroscience. Neuron 101: 394-398 (2019).


Greely H et al, Rommelfanger K. Neuroethics Guiding Principles for the NIH BRAIN Initiative. J. Neuroscience 38(5): 10586-10588 (2018).

GNS Delegates, Rommelfanger, KS* et al. Neuroethics Questions for Neuroscientists in the International Brain Initiatives, Neuron, 100(1): 19-36 (2018).


Rommelfanger KS* and Boshears P. The Rubicon Already Crossed AJOB Neuroscience 8:4 197-199 (2017).

Wolpe PR, Rommelfanger, KS. and the Biotechnology and the Ethical Imagination Summit Delegates. The BEINGS Summit, Statement of Principles. Nature Biotechnology 35: 1050-1058 (2017).

Ramos KM, Rommelfanger KS, Greely HT, Koroshetz WJ. Neuroethics and the NIH BRAIN Initiative Journal of Responsible Research Innovation 5(1): 122-130 (2017).

Rommelfanger KS*, Rapaport MH, Factor SA, LaRoche S, Rosen P, Young R. Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future. Frontiers in Neurology 8: 1-7 (2017).

Purcell RH and Rommelfanger KS*. Biometric Tracking: From Professional Athletes to Consumers. American Journal of Bioethics 17: 72-74 (2017).


Sarrett JC and Rommelfanger KS*. Commentary: Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism. Frontiers in Public Health, Child Health and Human Development. 3: 272 (2015).

Purcell RH and Rommelfanger KS*. Internet-based brain training games, citizen scientists, and neuroprivacy of big data: Ethical issues in unprecedented virtual territories Neuron 86:356-359 (2015).

Rommelfanger KS* and Johnson LSM. What Lies Ahead for Neuroethics Scholarship and Education in Light of the Human Brain Projects. AJOB Neuroscience 6: 1-3 (2015).


Trimper JB, Wolpe PR, Rommelfanger KS*. When I Becomes We: Ethical implications of emerging brain-to-brain interfacing technologies. Frontiers in Neuroengineering 7:4 (2014).

Meltzer CC, Sze G, Rommelfanger KS, Kinlaw K, Banja J, Wolpe PR. Guidelines for the Ethical Use of NeuroImages in Medical Testimony: Report of a Consensus Conference. Am J Neuroradiol 35: 632-637 (2014).


Rommelfanger KS*. Attitudes on Mind Over Matter. Placebos for Psychogenic Disorders 4:9-15 AJOB Neuroscience (2013).

Rommelfanger KS*. Placebo for Psychogenic Disorders. Nat Rev Neurology9:351-356 (2013).

Books & Chapters

Selected Highlights

Johnson, LSM and Rommelfanger KS (Editors). The Routledge Handbook of Neuroethics, New York, NY: Routledge, 2018.

Purcell R and Rommelfanger KS. Neuroscience online: real ethical issues in virtual realms In Handbook of Neuroethics, Johnson LSM and Rommelfanger KSR (Eds) New York, NY: Routledge, Chapter 17, 2018.

Grubbs L and Rommelfanger KS. Placebo for Psychogenic Disorders: Ethics, Illness and Treatment Narratives. In Handbook of Neuroethics, Johnson LSM and Rommelfanger KSR (Eds) New York, NY: Routledge Chapter 7, 2018.

Rommelfanger KS*. Placebo beyond controls: The neuroscience and ethics of navigating a new understanding of placebo therapy. Neuroethics: Anticipating the future [2nd Edition] Looking to the future, Chapter 12, pg.214-234, Oxford University Press, 2017.

Rommelfanger KS*. The role of placebo in diagnosis and treatment of functional neurologic disorders. Handbook of Clinical Neurology. Volume 139, Chapter 49, pg. 607-617 in Functional Neurological Disorders, Elsevier, 2016.